MGMT 368 Business Ethics
Week 4 Deontological Second Paper Dropbox # 5
April 15, 2012
Direct-to-consumer drug advertising - Deontological Point ofView For many years, consumers relied and depended on the expertise and knowledge of physicians to make decisions on their pharmaceutical needs. Before 1985, prescription drugs could not be advertised directly to consumers. The U.S Food and Drug Administration passed a rule that allowed Direct-to-consumer drug advertising in 1985. This ruling was passed on the condition that warning information was provided about side effects and other dangers. “Directto-consumer advertising is the promotion of prescription drugs through newspaper, magazine, television, and internet marketing. Drug companies also product a range of other material, including brochures and videos, that are available in doctors office or designed to be given to patients by medical professions or via patient groups.” ("Source Watch") Currently the United States and New Zealand are the only two developed nations that allow direct-to-consumer advertising of pharmaceutical drugs. Other nations feel that direct-to-consumer advertisements are often just sales pitches that pressure doctors to make unnecessary prescriptions. ("Prescription drug ads") I favor direct-to-consumer advertising/marketing of pharmaceutical drugs and believe that it is ethical. In this paper I will be using the deontological ethics of Immanueal Kant' s Theory to support my reasoning. Immanuel Kant developed the most influential deontology. Kant argues that to act in the morally right way, people must act from duty.
I favor the direct-to-consumer advertising. The U.S. Food and Drug Administration and the government's duty is to provide channels for pharmaceutical companies to directly communicate with its consumers. The purpose of this communication is to inform consumers about a variety of possible drugs to treat them. It is the duty of pharmaceutical companies to advertise...
Please join StudyMode to read the full document